| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accounting for Uncertainty in Decision Analytic Models Using Rank Preserving Structural Failure Time Modeling: Application to Parametric Survival Models
|
Bennett, Iain
|
|
2018
|
21 |
1 |
p. 105-109
|
artikel
|
| 2 |
An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds
|
Nussbaum, Samuel R.
|
|
2018
|
21 |
1 |
p. 27-32
|
artikel
|
| 3 |
Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials
|
Papp, Kim A.
|
|
2018
|
21 |
1 |
p. 1-8
|
artikel
|
| 4 |
Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments
|
Janssen, Ellen M.
|
|
2018
|
21 |
1 |
p. 59-68
|
artikel
|
| 5 |
Copyright/Subscription
|
|
|
2018
|
21 |
1 |
p. iv
|
artikel
|
| 6 |
Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care
|
GC, Vijay Singh
|
|
2018
|
21 |
1 |
p. 18-26
|
artikel
|
| 7 |
Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer
|
Hashim, Mahmoud
|
|
2018
|
21 |
1 |
p. 9-17
|
artikel
|
| 8 |
Editorial Board
|
|
|
2018
|
21 |
1 |
p. i
|
artikel
|
| 9 |
EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom
|
Hernandez Alava, Monica
|
|
2018
|
21 |
1 |
p. 49-56
|
artikel
|
| 10 |
EQ-5D: Moving from Three Levels to Five
|
Lloyd, Andrew
|
|
2018
|
21 |
1 |
p. 57-58
|
artikel
|
| 11 |
Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available: A Validation Study Comparing Medication/Prescriber Visit–Based Algorithms with Diagnosis Codes
|
Dobson-Belaire, Wendy
|
|
2018
|
21 |
1 |
p. 110-116
|
artikel
|
| 12 |
Instructions for Authors
|
|
|
2018
|
21 |
1 |
p. I-IX
|
artikel
|
| 13 |
Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States
|
Brown, Joshua D.
|
|
2018
|
21 |
1 |
p. 33-40
|
artikel
|
| 14 |
Standards for Instrument Migration When Implementing Paper Patient-Reported Outcome Instruments Electronically: Recommendations from a Qualitative Synthesis of Cognitive Interview and Usability Studies
|
Muehlhausen, Willie
|
|
2018
|
21 |
1 |
p. 41-48
|
artikel
|
| 15 |
Table of Contents
|
|
|
2018
|
21 |
1 |
p. ii-iii
|
artikel
|
| 16 |
The Burden of Peristomal Skin Complications on an Ostomy Population as Assessed by Health Utility and the Physical Component Summary of the SF-36v2®
|
Nichols, Thom R.
|
|
2018
|
21 |
1 |
p. 89-94
|
artikel
|
| 17 |
Trading Bankruptcy for Health: A Discrete-Choice Experiment
|
Shrime, Mark G.
|
|
2018
|
21 |
1 |
p. 95-104
|
artikel
|
| 18 |
Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes
|
Rowen, Donna
|
|
2018
|
21 |
1 |
p. 69-77
|
artikel
|
| 19 |
Women’s Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment
|
Sicsic, Jonathan
|
|
2018
|
21 |
1 |
p. 78-88
|
artikel
|
Tijdschrift beschrijving